PharmaBoardroom

Interview with Christian Rodié, FEFIS – Fédération…

FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different…

Interview with André Syrota, Director – General, INSERM…

After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a…

Interview with Hagen Pfundner, CEO, Roche Germany

Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world's…

Interview with Henri Vacher, Secretary General, SICOS –…

Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical…

Interview with Noël Renaudin, President, Comité Economique des…

The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the…

Interview with Jean Marimbert, Director General, Agence…

The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market.…

Argentina – Where Crisis Brings Opportunity

Boasting three Nobel Prize winners from the life sciences, Argentina has had a long history of innovation. Immigration from Europe at the…

Jean-François Dehecq – Chairman, Sanofi-Aventis

What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them?…

Interview with Thomas Klein, Ceo and Founder, Cytolon

You have a wide professional experience that goes from financial adviser to biotechnology entrepreneur, passing through software business and…

Interview with Wolfgang Söhngen, CEO, Paion

Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry, academia and consulting help you…

Interview with Martin Stapf, Global BU Director Oncology, Hikma…

One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm and Thymoorgan in 2007. How…

Interview with Klaus Heumann, Founder and CEO, Biomax Informatics

Your interest in bioinformatics has run though your academic career and now into your business career as CEO and founder of Biomax Informatics; what…

Tagged with